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EVALUATION OF BEHAVIOR IN TRANSGENIC MOUSE MODELS TO 
UNDERSTAND HUMAN CONGENITAL PAIN CONDITIONS 
 
 
DANIEL B. BULLOCK 
ABSTRACT 
Background: Containing a brain for signal processing and decision making, and a 
peripheral component for sensation and response, the nervous system provides higher 
organisms a powerful method of interacting with their environment. The specific neurons 
involved in pain sensation are known as nociceptors and are the source of normal 
nociceptive pain signaling to prompt appropriate responses. Though acute 
hypersensitization can be advantageous by encouraging an organism to allow an injured 
area to heal, chronic pain conditions can be pathological and can markedly reduce quality 
of life. While a variety of genes have been associated with congenital pain conditions, 
two rare cases examined in this study have not had their mutated genes identified. 
Potassium voltage-gated channel subfamily H member 8, or KCNH8, is involved in 
regulating action potential production and propagation, and has not been linked with pain 
processing of any kind to date. Here, a male patient evaluated at Boston Children’s 
Hospital contains a novel single-base KCNH8 mutation and possesses an extremely low 
sensitivity to cold temperatures and mechanical pain, but a higher sensitivity to warmer 
temperatures. A separate protein, intersectin-2, or ITSN2, normally functions in clathrin-
mediated endocytosis and exocytosis. A second patient at Boston Children’s Hospital 
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expresses a previously-unseen point mutation in ITSN2 and experiences erythromelalgia, 
characterized by episodes of intense pain and red, swollen limbs during ambient warm 
temperatures. Through the use of Clustered Regularly Interspaced Short Palindromic 
Repeats (CRISPR)/Cas9 genome editing, this study will produce these specific genetic 
mutations in mouse lines to explore their effects on mammalian behavior.  
Objectives: This project employs two transgenic mouse models to study the behavioral 
phenotypes associated with rare potentially damaging mutations in KCNH8 and ITSN2 
exhibited in the human patients. Through these experiments, a greater understanding of 
neural pain signaling and sensitivity changes can occur. 
Methods: The differences in temperature preference of KCNH8 and ITSN2 mutant mice 
compared to wild type mice lacking these mutations was studied using thermal plates 
under cold and warm conditions. Direct application of acetone and von Frey filaments to 
mouse paws was used to study cold and mechanical sensitivity. Further testing of 
stamina, anxiety, coordination, and strength were also evaluated.  
Results: A marked decrease in sensitivity to von Frey stimulation (p<0.01) and acetone 
administration (p<0.05) was observed in KCNH8 mutant mice. Thermal preference 
testing demonstrated a decreased preference for warmer temperatures as compared to 
wild type mice. In addition, anxiety levels were also observed to be slightly higher in 
these mutant KCNH8 mice (p<0.05). The mutant ITSN2 mice spent less time at cooler 
temperatures, though surprisingly they significantly preferred warmer conditions as 
compared to their wild type littermates. A full and partial reversal of these temperature 
preferences was demonstrated in cold and heat thermal conditions respectively after 
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intraperitoneal gabapentin injection, which normalized the mice toward wild type 
behavior.  
Conclusions: Data from the KCNH8 mutant mouse model indicates an aversion to 
warmer temperatures and a decreased ability to detect cold or mechanical pressure, much 
like the human patient. The mutant ITSN2 mice were less likely to spend time at cooler 
temperatures, indicating heightened sensory sensitivity, but their preference for warmer 
temperatures suggests a possible desensitization of the affected nociceptors. These results 
often mirror the patient’s phenotype, but the preference for ambient warmer 
environments appears opposite to the patient. As the ITSN2 mice feel discomfort at 
cooler temperatures, a proposed desensitization at warmer temperatures would result in a 
more comfortable environment and could explain the observed preference. The trends 
toward normal neural firing rates achieved through gabapentin injection suggest that the 
aberrant responses in mutant ITSN2 mice is due to altered sensitization, but additional 
examination under these conditions with a larger group of mice is necessary to further 
unravel these signaling pathways. However, these extremely encouraging data introduce 
two new molecular targets for acute pain control. 
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INTRODUCTION 
Nervous System Circuitry 
The nervous system is imperative to a higher organism’s successful interaction 
with its external environment. Through the integration of signal detection, central 
processing, and response, the system provides a means of recognizing and adapting to 
environmental stimuli. Mammals contain a central nervous system (CNS), usually 
consisting of a brain, a brainstem, and a spinal cord, and is responsible for signal 
transduction, processing, and guiding decisions. The CNS acts together with the 
peripheral nervous system (PNS), which both receives input from the environment 
through afferent axons and acts on processed information via efferent neurons (DeLeo, 
2006; Fishman, 2007). 
In the CNS, each individual neuron contains dendrites, which receive signals from 
other neurons, a cell body for signal integration and processing, and an axon, which 
allows neural signals to be transmitted to further neurons via neurotransmitter release at 
synapses (Fishman, 2007; Valenstein, 2002). Neurons in the PNS are pseudo-unipolar, 
meaning they contain a single axon that is split into two branches. One branch runs to the 
peripheral tissue and the other into the spinal cord. PNS afferents are able to transduce 
many environmental stimuli including visual, oral, thermal, mechanical, and audible 
inputs through a variety of cell-surface receptors and internal signaling cascades 
(Chahine & O’Leary, 2014). Among these abilities, one of the most important roles of the 
PNS is pain perception. In acute cases, this is advantageous as it can provide a warning of 
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a danger, as well as encourage an organism to rest a damaged area of its body to promote 
recovery (Basbaum, Bautista, Scherrer, & Julius, 2009). 
 
Nociceptors: Pain Sensation and Transmission 
The specific peripheral sensory neurons for detecting pain are referred to as 
nociceptors. Their outer axonal terminals are found on tissue surfaces to interact with the 
environment, while the associated cell bodies are located in the internal dorsal root 
ganglia (DRG) near the spinal cord (Basbaum et al., 2009). These cell bodies connect via 
a central axonal branch with the central nervous system for pain signal processing. Many 
nociceptors are poly-modal, they possess receptors for multiple pain stimuli, meaning a 
single neuron may be able to detect the pain of a sharp knife as well as a burning candle. 
This is accomplished by separate signaling pathways present in the same cell. Though 
details of these pathways are not fully elucidated, surface-level transient receptor 
potential (TRP) channels have been identified in the sensations of both cold (TRPM8 and 
possibly TRPA1) and heat (TRPV1, TRPA1, TRPV2 and TRPV3). They also likely have 
a role in detecting mechanical pain stimuli and are involved in altering sensory threshold 
in inflammatory conditions (B. K. Campbell et al., 2017; De Caro et al., 2018).  
While TRP channels transduce cold, heat and other sensory inputs, they work in 
conjunction with a combination of voltage-gated sodium and potassium channels that 
transmit action potentials to the CNS. Among the sodium channel genes specifically 
expressed in nociceptors is the sodium voltage-gated channel alpha subunit 9 (SCN9A), 
which codes the Nav1.7 protein. This channel has been strongly linked to the 
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transmission of peripheral pain signals (Nassar et al., 2004) with studies in mice (Isensee 
et al., 2017) and humans(Cox et al., 2006; Klein et al., 2013) demonstrating distinct pain 
phenotypes when the highly conserved amino acids in the Nav1.7 protein sequence are 
mutated. 
Interestingly, certain gain of function mutations of SCN9A produce a condition 
known as erythromelalgia. This rare hypersensitive state manifests as spontaneous 
episodes of painful, swollen, and red limbs when at room temperature or warmer, and is 
heightened during exercise (Yang et al., 2004). It is characterized by lower thresholds for 
activation of voltage-gated sodium channels, allowing a greater number of action 
potentials and thus a higher sensation of pain for a given stimulus (Klein et al., 2013). 
   
  Neuropathic Pain: Hyperalgesia and Allodynia 
  A variety of voltage-gated sodium and potassium channels provide precise 
regulation of nervous system excitability. However, conditions that produce neuropathic 
pain alter neuronal sensitivity (Costigan, Scholz, & Woolf, 2009). Hyperalgesia is a 
hypersensitive state in which the nervous system reacts more aggressively to noxious 
stimuli, and can result in extreme discomfort upon exposure (J. N. Campbell, Raja, 
Meyer, & Mackinnon, 1988). Factors such as inflammatory mediators may also change 
pain thresholds in the damaged tissue, resulting in this condition (Chessell et al., 2005). 
Allodynia is a condition most associated with neuropathic pain following neuronal 
damage. In this situation, stimuli that would not normally evoke a painful response are 
sensed by the injured PNS as painful. Consequently this condition can result in episodes 
of intense pain activated by normally innocuous stimuli, such as light touch (Nassar et al., 
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2006). Neuropathic pain is mainly comprised of tactile and cold allodynia, as well as 
spontaneous pain. It can stem from a variety of disorders, including long-term effects of 
diabetes or HIV (Schoeniger-Skinner et al., 2007) or as a result of direct nerve injury 
(Nassar et al., 2006) 
 
Role of Genetics in Pain Perception 
 Though environmental stimuli and disease states can alter neural sensation and 
signaling, recent research has focused on the role of genetics in nociception. Multiple 
studies of siblings (Norbury, MacGregor, Urwin, Spector, & McMahon, 2007) and of the 
general population (Nielsen et al., 2008) indicate a combination of environmental and 
genetic factors act on each person’s unique somatosensory sensitivities. Inherited pain 
conditions can stem from a variety of factors, some of which can result in a loss of 
nociceptor function, producing conditions of insensitivity (Akopian et al., 1999).  
Additionally, studies indicate that the thermal and mechanical receptors involved 
in signal transduction can be mutated to give both positive and negative pain phenotypes 
(Diatchenko et al., 2005; Park et al., 2007). Others have noted congenital pain conditions 
with mutations in the sodium channels (Bennett & Woods, 2014) and potassium channels 
(Costigan et al., 2010) in patients. Together, these results demonstrate that genetic factors 
are pivotal in determining an individual’s pain perception. These baseline qualities are 
also integrated with and influenced by environmental stimuli, both acutely via changes in 
temperature or in the presence of noxious stimuli, or chronically through disease or 
damage to the nervous system. This study will primarily focus on the role of single-base 
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mutations in genes not previously documented to have a role in acute pain regulation. 
The resulting effects on pain phenotype will support the growing understanding of the 
molecular mechanisms that underlie pain perception. 
 
CRISPR/Cas9 Genetic Editing 
CRISPR/Cas9 is a novel technique that allows fast gene editing within the 
genome. A common strategy is based on a bacterial defense mechanism that uses a 
CRISPR-associated protein-9 (Cas9) nuclease to cut invading viral DNA and incorporate 
portions of it into the prokaryotic genome. Thus, CRISPR/Cas9 allows the bacteria to 
detect and defend itself against any recurrences of the threat (Barrangou et al., 2007; 
Bolotin, Quinquis, Sorokin, & Ehrlich, 2005). In recent years, CRISPR/Cas9 has been 
modified to permit efficient editing of genomic DNA for scientific studies and potential 
clinical treatments. 
The type II CRISPR/Cas9 genome editing technique is commonly used to edit 
specific individual DNA bases. This system directs a bacterial Cas9 endonuclease to a 
chosen region of a mammalian double-stranded chromosomal deoxyribonucleic acid 
(dsDNA) using a single guide ribonucleic acid (sgRNA) that can be synthesized in the lab 
(Chylinski, Makarova, Charpentier, & Koonin, 2014). The Cas9 enzyme then induces a 
cut at a specific base pair in the host genome relative to this guide. The sgRNA acts to 
hybridize almost completely with the host DNA target site except at specific sites which 
will vary from the host DNA. As the cell produces a repair response, mutations are 
accurately placed into the genome. Among the natural mutations that can be recreated by 
this method are point mutations that inactivate splice sites in the pre-mRNA, resulting in 
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intron retention. Alternatively, single genomic mutations within the gene’s coding 
sequence can be produced which result in an altered amino acid, potentially altering the 
structure or function of the protein produced. This powerful technique can use several 
guide sequences at once to produce multiple simultaneous and precise genome edits or 
deletions (Cong et al., 2013). 
CRISPR/Cas9 genome editing has been extensively used in mice (Shen et al., 
2013) and other organisms ((Li et al., 2013) as a means of producing accurate laboratory 
animal replications of human mutation-based disease models. As the sites where rare 
disease mutations occur are extremely important for protein function, they are conserved 
across evolution as far back as flies or fish. The use of CRISPR/Cas9 genome editing in 
mice has also allowed generation of knockout and knock-in gene models that can produce 
dramatically altered phenotypes in mice (Platt et al., 2014).This study will use 
CRISPR/Cas9 genome editing to replicate potentially damaging patient derived 
mutations within mouse models. Through these animal models generated, we are 
examining if these mutations cause an altered phenotype that is consistent with the 
children suffering various congenital pain syndromes. 
Two recent studies have detailed the use of the CRISPR/Cas9 system in mice for 
reproducing human diseases with pain phenotypes. The first of these is neurofibromatosis 
type 1, a rare autosomal dominant disease characterized by episodes of severe pain in 
humans. By introducing a CRISPR mutation into the neurofibromin gene, a manifestation 
of the disease symptoms was produced and revealed increased voltage-gated calcium and 
sodium channel activity in DRG neurons. The resulting hyperalgesia confirmed a more 
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accurate understanding of the specific proteins involved in the disease (Moutal et al., 
2017). The second study demonstrated pain insensitivity produced in male mice upon 
rare mutations in methyl CpG binding protein 2 (MECP2), a gene required for normal 
nerve function. Mutations in MECP2 are often direct factors in autism and Rett syndrome 
development. A CRISPR/Cas9-mediated removal of eight conserved amino acids in this 
region produced heightened anxiety, lowered motor and cognitive activity, and decreased 
pain sensitivity in mice (Xu et al., 2018). The following study focuses on using CRISPR 
for reproducing rare human pain conditions in two mouse models, using behavioral tests 
to evaluate symptoms and neural activity.  
 
A Voltage-Gated Potassium Channel Mutation Causes Increased Pain Tolerance 
The first of these cases is Jeffrey, a male child from Connecticut, with a mutation 
in one copy of his potassium voltage-gated channel subfamily H member 8 (KCNH8) 
gene. Information regarding Jeffrey’s case was obtained through direct communication 
with Dr. Charles Berde and Dr. Catherine Brownstein of Boston Children’s Hospital 
(BCH), who analyzed his phenotype and performed genetic screening. It is hypothesized 
that the KCNH8 mutation causes a damaged protein acting in a dominant negative 
fashion within the cell. This in turn manifests as altered neuronal phenotype without the 
cell recognizing the issue. In mice, the KCNH8 channel is specifically expressed in two 
structures. It is highly expressed in the pituitary gland as well as in the DRG (see 
biogps.org/#goto=genereport&id=211468). Its roles include regulating neural pathway 
excitability (Zou et al., 2003).  
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The patient’s KCNH8 gene contains a guanine to adenine mutation. This single-
base change results in an RNA transcript that retains Intron 15, which is normally excised 
during RNA processing prior to protein translation. This specific base change removes 
the splice site at the end of the intron, resulting in its retention. Further, when the 
processed mRNA is translated, the retained intron contains an early stop codon, 
producing a truncated KCNH8 protein chain with altered properties. This research 
proposes that this altered protein dimerizes with other KCNH8 proteins, including normal 
copies (as the patient is heterozygous for this change), to produce a final quaternary unit 
potassium channel. It is hypothesized that this channel cannot be controlled correctly, due 
to the inclusion of at least one mutant KCNH8 chain. 
Studies of the patient reveal low sensitivity to mechanical sensation and a high 
tolerance to cold temperatures, including developing frostbite on one hand after touching 
a cold metal pole in the New England winter without discomfort. The patient also reports 
overheating easily and requires a cooling vest during exercise and in the summer. 
Curiously, despite an insensitivity to cold felt through the skin (i.e. through the sensory 
nerves), the child is able to feel relief from the cooling vest, perhaps indicating an ability 
to detect internal body temperature through the autonomic nervous system, which is also 
altered by this mutated potassium channel. Jeffrey’s intelligence is above average and 
while social, he has been described as slightly quirky. Figure 1 indicates that the child’s 
father also possesses an ability to withstand cold temperatures felt dermally, suggesting 
the congenital dominant negative phenotype may have been passed from father to son. 
Thus, the observed potentially damaging mutation in KCNH8 has never been 
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documented in any other person yet is shared between father and son, as analyzed and 
confirmed through genetic screening by Dr. Catherine Brownstein of BCH. 
 
 
Figure 1: A depiction of the dominant negative KCNH8 mutation affecting both father and son. Here, 
a trait map (A) illustrates that both Jeffrey and his father are affected by the potassium channel mutation. 
This mutation may result in a higher tolerance of cold temperatures (B), especially in Jeffrey, as compared 
to his mother and a reference patient population. Dotted lines represent the dispersion of the threshold 
temperature in reference patients. Data was obtained through an analysis of the patient and his family by 
Dr. Charles Berde, MD, PhD, Chief of the Division of Pain Medicine at Boston Children’s Hospital. 
 
Interestingly, neither these symptoms nor the KCNH8 channel have been linked 
with any previous pain studies, indicating potential novel pain signaling pathways. 
Through a CRISPR mouse model of this point mutation, this study will examine mice 
under conditions that test direct sensory mechanical and cold sensitivity, the ability to 
distinguish cold and heat environments, and other phenotypes. 
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A Mutated Transport Protein Results in Episodes of Pain and Heat Discomfort 
The second case of interest is a female child, Sarah from Minnesota with 
erythromelalgia, as assessed and documented by Dr. Charles Berde of BCH, who directly 
reported these findings to this laboratory group. Following exome sequencing of the 
patient-mother-father trio, a novel potentially dominant negative mutation in the 
Intersectin-2 (ITSN2) protein was identified in Sarah. This single nucleotide mutation 
results in one amino acid change in a highly conserved region of the protein, which was 
obtained through personal communication with Dr. Catherine Brownstein of BCH, who 
performed this screening. The intersectin protein mediates extracellular transport 
signaling through modulating clathrin-coated vesicle formation. ITSN2 is found to be 
localized in the sensory neurons present in the DRG, indicating a potential role in 
regulating neurotransmitter release and reuptake in the PNS (Pucharcos, Estivill, & de la 
Luna, 2000). To regulate clathrin-mediated endocytosis and exocytosis, the SRC 
Homology 3 Domain (SH3) domain of ITSN2 is linked to with-no-lysine protein kinase 1 
(WNK1). In addition to ITSN2, WNK1 is found to be localized in nervous tissue, and 
heavily expressed in the DRG throughout development (Shekarabi et al., 2013). Certain 
congenital mutations in WNK1 can result in neuropathic pain through preventing normal 
chloride transport and allowing uninhibited signaling (Kahle et al., 2016). This potential 
for damaged nervous activity provides a possible functional link of the DRG-localized 
ITSN2 protein and WNK1. 
The female child’s ITSN2 gene contains a cytosine to thymine mutation, resulting 
in a serine to phenylalanine change in the translated protein. The mutation and phenotype 
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are de novo to the patient, meaning that this mutation is specific to Sarah and that it 
occurred in her development. This potentially damaging mutation is in a region of ITSN2 
which is extremely well conserved as far back as fish, and it has never been documented 
in another person. Consistent with it being the cause of Sarah’s pain condition, her 
parents are unaffected with no abnormal pain phenotypes. The mutated protein may result 
in altered sensory excitability, leading to episodes of pain and red, inflamed limbs 
(erythromelalgia) when exposed to heat. During these episodes, ice and cold are helpful 
to alleviate the pain. Sarah also enjoys exercise, including skiing. When not in pain crisis, 
Sarah potentially may display a higher sensitivity to cold due to greater neuronal 
excitability, though this and her sensitivity to tactile stimulation have not yet been 
assayed to date. This study uses a CRISPR/Cas9 mouse model of the altered ITSN2 
protein to examine thermal and mechanical behavior. It also uses drug targeting in these 
mice to alleviate hypersensitivity and help unravel details of their chronic pain 
processing. 
 
Examination of Temperature Preference 
A standard means of measuring temperature preference in mice is a two-plate 
thermal assay. A previous study indicates that wild type C57BL/6J mice are most 
comfortable at a floor plate temperature of 33.9°C (Alexandre et al., 2017). Ranges far 
above or far below this can be uncomfortable and eventually can become painful to the 
mice. The preference assay involves maintaining one plate at a constant 25°C, while the 
other plate is decreased or increased in increments from this same starting point 
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(Descoeur et al., 2011). The colder 25°C constant temperature plate is mildly noxious to 
the mice. The thermal plate assay can be used to examine mice in temperatures as low as 
9°C and as high as 49°C. During heat thermal testing, any preference or lack of 
preference to the optimal 33.9°C temperature can be examined. As both the mutant 
KCNH8 and mutant ITSN2 human patients have abnormal temperature sensitivity, 
thermal plate testing can provide a basis for comparison between the transgenic mouse 
models and human patients.  
 
Gabapentin in Pain Relief  
Sarah has shown relief from her pain episode symptoms with gabapentin 
administration. Gabapentin has routinely been used as an analgesic in neuropathic pain 
(Kim et al., 2017; Peng, Li, Qu, & Wu, 2017). Through targeting voltage-gated calcium 
channels (Kusunose et al., 2010), it can relieve central sensitization by reducing 
hypersensitivity and restoring normal neural signaling and synapse firing rates. This 
study examines the effect of intraperitoneal gabapentin administration on mutant ITSN2 
mice during cold and hot temperature preference studies. 
 
Examining Mechanical Stimulation Using von Frey Filaments 
Direct application of von Frey filaments to the skin in both mouse and human 
models has widely been used as a method of measuring tactile sensitivity since its 
inception in 1896 (Chaplan, Bach, Pogrel, Chung, & Yaksh, 1994; Norrsell, Finger, & 
Lajonchere, 1999; von Frey, 1896). The testing employs filaments of varying strength 
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and are traditionally applied using the Up-Down method to determine the 50% 
withdrawal threshold, or the point of discomfort, in mammals. The test is useful to study 
the effects of drugs (Yamamoto, Suzuki, Ono, Kume, & Ohsawa, 2016) and has been 
heavily employed in altered neuropathic states (Gao, Feng, & Ju, 2017; Pannell et al., 
2016). Here, direct measurement of the mutant mice will allow an assessment of any 
direct or indirect effects of their mutations on mechanosensitivity. 
 
Additional Tests of Sensation, Stress, and Coordination  
 The assessment of acetone applied dermally as a measure of cold sensitivity is a 
standard thermal mouse assay (Nieto et al., 2012). A small amount of the compound is 
applied to the hind paw of a mouse and its licking or grooming responses are recorded 
over a period of time. This test is useful to observe any effects of abnormal nociceptor 
signaling. Here, it will be used to compare the mutant KCNH8 and ITSN2 mice with 
their wild type littermates to measure differences in their ability to detect a dermally 
applied cold stimulus. 
Activity wheels are a standard measure of stamina as well as pain in mice. Mice 
are traditionally housed in cages that contain unobstructed access to metallic wheels. The 
amount of time spent and distance traveled on these wheels can be useful in objectively 
comparing healthy mice to those with inflammatory and other chronic conditions (Cobos 
et al., 2012). An additional behavioral test often used to assay the effects of drugs or 
conditions on anxiety in mice is the elevated plus maze (EPM). The plus-shaped device 
contains two open arms perpendicular to two enclosed arms, along with a camera to 
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record mouse activity. Studies demonstrate that mice typically spend the majority of their 
time in the enclosed arm, in which they experience lower levels of anxiety and plasma 
corticosteroids (Pellow, Chopin, File, & Briley, 1985). As a result, they reside less in the 
open arms of the maze, and anything that increases anxiety levels can be expected to 
further reduce the time spent in these arms (Walf & Frye, 2007). Here, this apparatus will 
be used to test the basal anxiety-like behavior in mutant mice relative to controls.  
Lastly, this study considers the effects of altered pain sensitivity on coordination 
and strength. A Rota-Rod apparatus consists of a large rotating cylindrical bar that 
accelerates from a preset speed. The time mice are able to remain on this bar before 
falling is recorded. This test is therefore useful in measuring any effects of pain or illness 
on balance and agility as compared to healthy or treated mice (Dyson et al., 2005). 
Similarly, the grip strength test directly measures the strength of an animal’s hind legs 
and can be used to understand any effect of altered pain states on limb strength (Allen et 
al., 2009; Montilla-García et al., 2017). This study will explore any possible effects of the 
KCNH8 and ITSN2 mutations on mice during these tests.  
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SPECIFIC AIMS 
It is hypothesized that the higher tolerance to cold temperatures and mechanical 
pain in patient one (Jeffrey) is due to a truncated KCNH8 protein, which would occur due 
to a splice site mutation in this gene. Likewise, it is likely that an altered ITSN2 protein 
in patient two (Sarah) results in her erythromelalgia phenotype of episodes of increased 
heat sensitivity and potentially other hypersensitive sensations. Therefore, this study will 
examine models of cold and hot temperature preference in mice harboring these specific 
mutations, to develop a greater knowledge of the association between genetic mutations 
and behavior in these “patient mimic” animal models. 
 
During painful episodes, Sarah expresses relief from her pain with gabapentin 
administration. Therefore, this study will expand on the thermal preference testing to 
include administration of the drug, to study changes in preference to cold or hot 
temperatures. Through these results, this research seeks to produce a stronger 
understanding of the effects of these mutations on neural signaling in order to potentially 
develop new treatments. 
 
Finally, we are also interested in the effects of the mutant KCNH8 channel and 
the mutated ITSN2 protein on mechanosensitivity, cognition, coordination, and strength. 
The data from these results can be compared to the symptoms of the human patients to 
understand the utility and limitations of these transgenic models.  
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METHODS 
Design of Targeting CRISPR sgRNAs and Mutant Oligos 
The CRISPR Design Tool (http://tools.genome-engineering.org) was used to 
design the guide RNA sequences that generate the desired on-target mutations in mice. 
Each contained 20 nucleotides preceding a protospacer adjacent motif (-NGG) sequence 
at the 3’ end. The synthetic CRISPR sgRNAs were purchased from Sigma Millipore (St. 
Louis, MO). The mutant oligo was designed according to the mutation site flanking 
region and ordered from Integrated DNA Technologies (IDT, Skokie, IL). Besides the 
target mutation, single-stranded oligodeoxynucleotides (ssODN) were designed with 
several silent mutation sites. These were added to create a signature of HDR (Homology 
Direct Repair) in the CRISPR generated mouse lines’ genome to aid in identification of a 
successful mutation event. 
 
One-Cell Embryo Injection  
CRISPR reagent solution was made of synthetic CRISPR sgRNAs (50 ng/μl), 
Cas9 protein (100 ng/μl), and mutant ssOligo donor (100 ng/μl) in injection media 
(10mM Tris pH7.9). This cocktail was injected into the pronuclei of fertilized, single cell 
mouse embryos. After mating, one-cell embryos were harvested from C57BL/6/Hsd 
donor females for microinjection, performed at the Mouse Gene Manipulation Core in the 
F.M. Kirby Neurobiology Center at Boston Children’s Hospital.  
The injections were performed on an inverted microscope (Nikon S2000, Tokyo, 
Japan) and embryos were transferred to potassium simplex optimized medium (KSOM) 
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until implantation. Injected embryos were surgically implanted into the oviducts of 
pseudo-pregnant female mice. The pregnancies were allowed to proceed full-term and tail 
biopsies from offspring were analyzed by PCR and/or sequencing for the presence of 
CRISPR/Cas9 edited mutations. 
 
Distribution of Mice and Cages for Testing 
All mice used in behavioral testing were housed in cages of five or fewer animals, 
with access to water and a chow diet (Lab Diet 5P76 Irradiated ProLab Iso Pro RMH 
3000, St. Louis, MO). Each cage contained either mutant KCNH8 or mutant ITSN2 mice, 
along with wild type (WT) littermates. Mice were between 8-14 weeks old when 
experiments were performed. A total of 23 KCNH8 mutant mice were used throughout 
testing. Two groups of ITSN2 mutant mice were used in thermal plate testing, including 
18 in the first group and 11 in the second group, which was also used for gabapentin 
testing. A total of 20 WT mice were used in KCNH8 experiments and 23 WT mice in 
ITSN2 experiments. All mice received appropriate care in agreement with the 
Institutional Animal Care and Use Committee (IACUC) of Boston Children’s Hospital 
under animal protocols 15-04-2928R and 16-01-3080R.  
 
Thermal Preference Testing 
To measure temperature preference of wild type, ITSN2 mutant, and KCNH8 
mutant mice, two BIO-CHP Cold Hot Plates (Bioseb, Pinellas Park, FL) were employed. 
Using the 2 Temperatures Choice Nociception Test software (Bioseb), one thermal plate 
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was kept at a constant 25°C, while the temperature of the other plate varied. During cold 
testing, this plate decreased from 25°C to 21°, 19°, 17°, 13°, and 9°C. Each temperature 
was maintained for three minutes before decreasing to the subsequent level. Heat thermal 
testing was conducted in the same manner, where temperatures increased from 25°C to 
29°, 33°, 37°, 41°, 45°, and 49°C, at three minutes per temperature. Trials were recorded 
through a black-and-white camera using Ethovision XT 11.5 software (Noldus, 
Wageningen, The Netherlands). This software was used to monitor and calculate the time 
spent in each plate through dynamic subtraction between dark mice and their lighter 
surroundings. Mice were left alone during trials to ensure no outside influence on results. 
This experiment was repeated with a second batch of mutant ITSN2 and WT mice, which 
was also used in gabapentin tests. 
 
Gabapentin Injections and Thermal Preference in ITSN2 Mice 
Intraperitoneal (IP) injections of gabapentin (Sigma Aldrich, St. Louis, MO) were 
administered in the second group of mutant ITSN2 mice and their WT littermates to 
examine effects of the analgesic on thermal preference. Using a metric weight scale 
(Tanita Corporation, China), mouse weight was recorded in grams. As indicated in Figure 
2, mice were IP injected with 30mg/kg body weight of gabapentin and returned to their 
cages for 30 minutes to allow the drug to take effect on the nervous system. Both cold 
and heat thermal preference plate tests were then performed, under conditions identical to 
the tests without gabapentin. Each trial lasted approximately 15 minutes. The time spent 
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in the plate with a changing temperature was monitored, recorded, and analyzed through 
Ethovision XT 11.5. 
 
Figure 2: Timeline and method of gabapentin injections. Mice with mutant ITSN2 proteins were IP 
injected with 30mg/kg BW gabapentin 30 minutes before either cold or hot thermal plate testing. Each 
thermal plate trial lasted 15 minutes. 
 
Von Frey Filament Testing 
To examine mechanical sensitivity in mice, Touch Test® Sensory Evaluators 
(North Coast Medical, Morgan Hill, CA) were used in traditional von Frey testing, as 
described in (Chaplan et al., 1994) and demonstrated on video in (Richner, Bjerrum, 
Nykjaer, & Vaegter, 2011). Briefly, mice were placed in small plastic dividers over a 
wire mesh floor and covered with a tarp for one hour to acclimate while experimenters 
were not present. When testing the mutant and wild type mouse models, the lower left 
paw of each mouse was gently pressed three times for two seconds beginning with a 0.6g 
filament. If a mouse flinched in response, a lower filament strength was tested (0.4g). If 
there was no response, a stronger filament (1.0g) was used. Up to nine trials were 
performed per mouse, with a mouse’s response dictating which filament to test. Testing 
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filaments ranged from 0.002g to 4g, and mouse sensitivity was recorded and calculated 
using the Dixon formula (50% 𝑡ℎ𝑟𝑒𝑠ℎ𝑜𝑙𝑑 (𝑔) = 10𝑋𝑓+𝑘𝛿/10,000), where 𝑋𝑓 = 
logarithmic value of the final von Frey filament tested, 𝑘 = tabular value (for the pattern 
of withdrawal response or no response), and 𝛿 = mean difference (in log units) between 
filaments. 
 
Acetone Administration 
After von Frey testing, mice remained under a tarp and a small volume of acetone 
(Thermo Fisher Scientific, Waltham, MA) was applied to the lower left paw. Each mouse 
was observed for 20 seconds, which was long enough for the acetone to evaporate. Brief 
instances of paw licking and discomfort were timed with a stopwatch. Three trials were 
performed and their values in seconds were averaged per mouse. Results were analyzed 
within the WT, mutant ITSN2, and mutant KCNH8 groups. 
 
Wheel Stamina Tests 
To examine effects of genetic mutations on mouse stamina and exercise level, 
mice were exposed to cages with 23cm by 5cm stainless steel running wheels and were 
allowed to run free without an experimenter present from 6:00pm to 9:00am. Wheels 
were linked to a computer running the ActiviWheel software (Intellibio, Seichamps, 
France), which recorded the distance traveled by each mouse in kilometers between the 
hours of 10:00pm to 6:00am. 
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Elevated Plus Maze Navigation 
To measure differences in mouse anxiety between CRISPR mice and WT, the 
EPM was employed. The mouse was placed in the center of the maze, facing an open 
arm, and was allowed to freely move for five minutes. Total time spent in the open arm 
regions was divided by the five-minute interval to study the mouse’s anxiety. The 
elevated video plus maze for mouse (Med Associates, Inc, St. Albans, VT) was 
illuminated with a near-infrared light (Med Associates, Inc), and mouse activity was 
recorded using dynamic subtraction in Ethovision XT 11.5 software. 
 
Rota-Rod Testing 
To test effects of the mutated ITSN2 and KCNH8 proteins on coordination and 
stamina, a Dual Species Economex Rota-Rod (Columbus Instruments, Columbus, OH) 
was used. Up to three mice were placed on a large rotating bar, which began accelerating 
from 4RPM at a constant rate of 0.1RPM/sec. Stopwatches at the base of the apparatus 
recorded the time in seconds that mice remained on the rotating bar and stopped as the 
mice landed on the platform below. Mice were allowed a repeat if their first trial was 
under 30 seconds, so that they could acclimate to the machine. 
 
Grip Strength Examination 
Assessment of possible effects of mutant ITSN2 and KCNH8 on muscle strength 
were performed using a BIO-GS3 Grip Strength Test (Bioseb). The device contained a 
sensitive bar for mice to grab and a screen to display strength in grams. To support the 
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mice, the experimenter held a wire mesh for the mice to grip with their front paws. The 
mice then held onto the device’s bar with their back paws. The mice were then gently but 
swiftly pulled back by their tails, and the resulting forces exerted on the bar were 
displayed on the screen. Each trial was conducted three times per mouse, and their 
arithmetic mean was used in analyses. 
 
Statistical Analyses 
Statistical significance was determined using the Student t-test for two groups, or 
two-way repeated measures ANOVA followed by post-hoc comparisons using GraphPad 
Prism 7. Data was considered statistically significant at p < 0.05 (using an *) with higher 
significance represented by additional asterisks. Bar graphs and line plots are presented 
as mean ± standard error (SE).  
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RESULTS 
Testing of Mutant KCNH8 Mice Across Multiple Sensory Assays Demonstrate Data 
Consistent with Changes in Thermal and Tactile Sensation 
Thermal plate testing behaviors in heterozygous KCNH8 mutant mice were 
compared to WT mice under the same conditions and are displayed in Figure 3A and 3B. 
In addition, von Frey filament (Figure 3C) and acetone response (Figure 3D) were 
recorded for KCNH8 versus WT mice. 
 
 
Figure 3: Studies of thermal preference, von Frey, and acetone in mutant KCNH8 mice versus WT. 
Mice heterozygous for the KCNH8 mutation were subjected to a decreasing (A) or increasing (B) range of 
temepratures on one plate while the second plate was maintained at 25°C. Each temperature was 
maintaeined for three minutes before decreasing (if below 25°C) or increasing (if above 25°C). KCNH8 
mice were compared to wild type mice under identical conditions. The y-axis indicates percent of time 
spent at each temperature, versus the unchanging 25°C plate. Von Frey filament testing results (C) for 
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KCNH8 and WT mice is illustrated, with the 50% mechanical threshold displayed along the y-axis. In (D), 
the time spent licking the lower left paw after acetone administration in the first 20 seconds is illustrated for 
both groups as the average of three trials. KCNH8 data is indicated in green, with WT mice in blue. n=20 
per group. Data is reported as mean ± SE. *p<0.05, **p<0.01. 
 
KCNH8 mutant and WT mice were subjected to temperatures ranging from 9°C 
to 49°C, as described in the methods, which is displayed in Figure 3A and 3B. The y-axis 
represents percent of time spent at each temperature, with the remaining time spent on the 
constant 25°C plate. At temperatures below and up to 29°C, there was no significant 
difference between the groups of mice. Results indicate that mutant KCNH8 mice spent 
only half of their time at 33°C and 37°C (p<0.05), much lower than the 80% of time 
spent by WT mice. Above this temperature, the two groups of mice were more consistent 
with each other. 
In Figure 3C, a significant difference (p<0.01) between KCNH8 mutant and WT 
groups was observed during von Frey testing. Mechanical sensitivity was decreased in 
the KCNH8 mice, represented by a much higher filament strength needed to elicit a paw 
withdrawal response versus the wild type group. In Figure 3D, a lower level of 
discomfort to the direct application of acetone was observed in the KCNH8 group versus 
the WT (p<0.05), expressed as less time licking the afflicted paw across an average of 
three trials per mouse. 
 
Additional Tests of Strength, Stamina, and Coordination Reveal Some Behavioral 
Changes in the KCNH8 Mutants 
All mice were assessed on activity wheels, an EPM, a Rota-Rod apparatus, and a 
grip strength test (Figure 4A-4D). These tests were used to assay a number of different 
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behaviors, including activity (wheels), cognition (EPM), balance and coordination (Rota-
Rod), and muscle strength and action (grip strength). 
 
Figure 4: Testing of stamina, anxiety, coordination, and strength in heterozygous KCNH8 mutants 
and WT mice. KCNH8 and WT mice were placed on running wheels overnight, and the total distance 
traveled was recorded from 10:00pm to 6:00am (A). Each mouse explored an elevated plus maze (EPM) 
for five minutes, with the percent of time in the open area recorded (B). Mice were placed on a Rota-Rod 
that accelerated from 0.4RPM at 0.1RPM/sec, and the time in seconds was recorded before the mouse fell 
(C). A grip strength device was employed to measure the force in mN each mouse exerted on a bar as it 
was pulled away (D). All experiments were conducted once, with n=20 per group. Data represents mean ± 
SE. *p<0.05. 
 
Some of the KCNH8 mice expressed reduced physical activity on overnight 
wheels compared to wild type mice (Figure 4A), though this was not a statistically 
significant finding. During EPM testing (Figure 4B), a significant increase in anxiety-like 
behavior (p<0.05) was observed in the KCHN8 mice, illustrated by a lower percent of 
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time spent in the open areas versus the WT mice. It appears balance coordination (Figure 
4C) and physical strength (Figure 4D) were not affected in KCNH8 mutant mice, 
suggesting these neural pathways are either unrelated to or unaffected by the truncated 
voltage-gated potassium channel. 
 
Examination of Mutant ITSN2 Mice Across Various Sensory Assays Demonstrate 
Results Consistent with Altered Thermal and Tactile Sensation 
Sarah’s erythromelalgia symptoms are similar to patients that suffer this disease 
via a pathogoloically mutated SCN9A gene, causing expression of a hyperactive Nav1.7 
channel at room temperature. Hypersentivity to heat could also lead to hypersensitivity to 
cold through similar signaling via alternate TRP channels. Sarah’s condition has been 
partially treated with gabapentin, thus we studied mice injected with IP gabapentin after 
baseline responses to temperature ranges were measured (Figure 5). 
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Figure 5: Thermal, drug, and tactile evaluations of mice with a heterozygous ITSN2 mutation. Mice 
with heterozygous mutant ITSN2 were subjected to a range of cool (A) or warm (B) temepratures on one 
plate while the second plate was maintained at 25°C. Each temperature was mainteined for three minutes 
before decreasing (if below 25°C) or increasing (if above 25°C). Mutant ITSN2 mice were compared to 
wild type mice under the same conditions. The y-axis indicates percent of time spent at each temperature, 
versus the unchanging 25°C plate. The test was repeated 30 minutes after intraperitoneal gabapentin 
injections in the same mice (labeled as Grp3) at temperatures most likely to show differences, and the 
results were plotted for cold (C) and warm (D) conditions. Included in these plots are plate data for the first 
group of ITSN2 mice (labeled as Grp2). Von Frey filament results (E) for ITSN2 and WT mice is 
displayed, measuring 50% mechanical threshold across the y-axis. In (F), the time spent licking the lower 
left paw after acetone administration is illustrated for both groups as the average of three 20-second trials. 
ITSN2 mouse data is indicated in red, and WT mice are in blue. n=20 per group. Error bars represent mean 
± SE. *p<0.05; **p<0.01. 
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As with mutant KCNH8 mice, mutant ITSN2 mice and their wild type littermates 
were exposed to temperatures ranging from 9°C to 49°C (Figure 5A and 5B). 
Interestingly, ITSN2 heterozygous mutants appeared to spend less time at each 
temperature below 25°C versus the wild type mice, with a significant difference observed 
at 19°C (p<0.05). Paradoxically, these mice also spent more time than WT mice in the 
ranges of 37°C-45°C, (including a significant difference at 41°C, where p<0.01) which 
might be expected to cause erythromelalgia and pain. (Figure 5B). After gabapentin 
injections, a partial reversal of cold (Figure 5C, p=0.169 at 19°C) and heat (Figure 5D) 
symptoms was potentially demonstrated in ITSN2 mice. The time spent at each 
temperature was closer to the behavior of the WT group at 21°C, 19°C, 37°C, and 41°C. 
Figure 5E illustrates a potential increase in mechanical sensitivity observed during 
von Frey testing in mutant ITSN2 mice. Mutant ITSN2 mice showed a slight, though 
statistically insignificant (p=0.176) tendency to respond to weaker von Frey filaments as 
compared to wild type mice, potentially suggesting higher baseline mechanical senstivity. 
Additionally, response to acetone administration in the ITSN2 mice was nearly identical 
to the WT mice, indicating equivelent responses to direct cold application (Figure 5F). 
 
Further Testing of Exercise, Anxiety, and Muscular Coordination Reveal a Lack of 
Correlation with the ITSN2 Point Mutation 
ITSN2 mutant and WT mice were tested on overnight activity wheels, an EPM, a 
Rota-Rod apparatus, and a grip strength test (Figure 6). These results provided further 
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insight into the specific effects of the mutation in mice and their correlation with Sarah’s 
symptoms. 
 
 
Figure 6: Comparison of stamina, anxiety, coordination, and strength in heterozygous mutant ITSN2 
mice versus WT mice. Heterozygous mutant ITSN2 mice and WT mice were placed on running wheels 
overnight, and the total distance traveled was recorded from 10:00pm to 6:00am (A). Each mouse explored 
an elevated plus maze (EPM) for five minutes, with the percent of time in the open arms recorded (B). 
Mice were placed on a Rota-Rod that accelerated from 0.4RPM at 0.1RPM/sec, and the time in seconds 
was recorded before the mouse fell (C). A grip strength device was employed to measure the force in mN 
each mouse exerted on a bar as it was pulled away (D). All experiments were conducted once, with n=20 
per group. Data represents mean ± SE. 
 
During the activity wheels test, a possible increase in distance traveled was 
observed in some of the ITSN2 mutant mice, though this was not significant across the 
entire group (p=0.1957) (Figure 6A). Elevated plus maze trials in ITSN2 mice (Figure 
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6B) revealed an identical behavior to wild type mice. Rota-Rod testing (Figure 6C) and 
grip strength assessment (Figure 6D) also demonstrated no difference between the two 
groups of mice.  
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DISCUSSION 
Studies of the nervous system have identified a combination of environmental and 
genetic contributions to altered pain states. With a recent shift towards examining the 
specific genes involved in pain perception, made more feasible through the incorporation 
of the CRISPR/Cas9 genome editing technique, animal studies are able to mimic human 
cases to assist in unraveling these phenotypes. This study focused on using animal 
models of the novel KCNH8 and ITSN2 mutations to greater understand the conditions 
experienced by Jeffrey and Sarah, respectively. 
 
A Unique Pain Phenotype Resulting from a Truncated KCNH8 Channel Reveals 
Agreement between Human and Mouse Models 
In common with many potassium channels, KCNH8 functions in regulating 
neural pathway excitability through acting as a brake in sodium current during action 
potential propagation. In addition, KCNH8’s expression profile in the pituitary and DRG, 
would suggest a role in hormonal control of certain bodily systems and somatosensation 
respectively, although these roles have not been previously investigated. As Jeffrey 
expressed a high tolerance to both external cold and mechanical stimuli, as well as 
marked discomfort at warmer ambient temperatures, this research aimed to examine these 
phenotypes in the mutant KCNH8 mouse line. As Jeffery and as his father harbor a 
mutated version of this potassium channel and have shared different phenotypes, further 
detailed analysis of both of their symptoms and genetics is required.  
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Cold thermal preference testing revealed similar behavior between mutant and 
wild type mice as temperature decreased below 25°C (Fig. 3C). These data indicate that 
the mutant KCNH8 mice prefer the 25°C plate over the colder temperatures. Jeffrey’s 
symptoms and history demonstrate an inability to detect noxious cold stimuli, though this 
experimental mouse data does not match with his symptoms. In contrast, KCNH8 mutant 
mice responded significantly less than their littermates to acetone administration (Figure 
3D), in agreement with Jeffrey’s higher tolerance for dermal cold stimuli (Figure 1B). 
These paradoxical data are hard to understand at present, but possibly the thermal plate 
data is measuring ambient cold whereas the acetone is measuring noxious cold. To test 
this, colder plate temperatures (4°C for instance) may be explored, as well as other 
techniques for measuring noxious cold, such as the cold plantar assay (Brenner, Golden, 
& Gereau, 2012). It is possible, however, that this mutated KCNH8 channel is not fully 
responsible for this phenotype and another mutated gene is working in concert to create 
the lack of noxious cold detection. Further clues to this could be found by reanalyzing 
Jeffery and his father’s shared pathological mutations with more intensive sequencing 
methods, a process which is underway in the lab and in collaboration with deCODE 
genetics (based in Reykjavík, Iceland). Using these cutting-edge methods, all of the 
potentially damaging rare mutations shared between father and son can potentially be 
identified, including those that may have been previously undetected.  
 Examining the heat thermal preference data for KCNH8 mutant mice in Figure 3B 
reveals no preference between warmer temperatures (up to 37°C) and the constant 25°C 
plate. As Jeffrey expresses discomfort after long exposure to warmer temperatures, these 
 33 
results seem to agree with his symptoms. This, coupled with the lack of preference for 
33.9°C (Alexandre et al., 2017) over a 25°C temperature indicates an influence of the 
CRISPR/Cas9-induced KCNH8 mutation on neural signaling pathways.  
When given a complete range of temperatures from 7°C to 50°C in a thermal plate 
preference test, wild-type mice actively prefer ambient warm temperatures at or around 
34°C (Alexandre et al., 2017) and consequently find the 25°C plate mildly aversive. The 
fact that KCNH8 mutant mice do not display this positive preference toward warmer 
temperatures up to 37°C (Figure 3B) suggests that this phenotype largely agrees with 
Jeffery’s discomfort during exposure to ambient warm temperatures. These data indicate 
but do not prove an influence of the CRISPR/Cas9-induced KCNH8 mutation on these 
ambient warm temperature sensing pathways. The mechanism of this phenotype requires 
further work. 
 In agreement with Jeffrey’s decreased mechanical normo-sensitivity, the von Frey 
assessment in KCNH8 mutant mice required a significantly stronger filament pressure for 
a paw withdrawal response versus the WT group (Figure 3C). Both this test result and 
Jeffrey’s reported lack of mechanical pain signifies that the truncated channel may have a 
role in modulating mechanical signal processing via afferent mechanoreceptors in the 
DRG. Further analysis of mechanical sensitivity in these mice is required, for instance 
using an analgesiometer to determine noxious mechanical threshold (Model 37215, Ugo 
Basile, Varese, Italy). 
 The additional tests shown in Figure 4 were performed to examine possible 
effects of the KCNH8 mutation on other behaviors. Through studying any relationship 
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between this point mutation and stamina, cognition, coordination, and physical strength, 
additional phenotypes not yet reported in Jeffrey could be explored. Jeffrey has 
previously experienced dizziness and discomfort after exercise, though a quantitative 
assessment of physical activity has not been reported. While some of the KCNH8 mutant 
mice spent less time on running wheels than the WT mice (Figure 4A), this distinction 
was not statistically significant (p=0.386). The high variability in both groups indicates 
that the assessment could be improved by increasing the sample size, and possibly 
altering the trial design. If further work does not improve experimental separation, then it 
can be concluded that these animals do not have a different activity phenotype. 
The increased anxiety-like behavior observed during the EPM examination 
(Figure 4B) suggests a possible connection between this mutated channel and autonomic 
stress regulation. Activation of the hypothalamo-pituitary-adrenocortical (HPA) axis 
represents a primary hormonal response to homeostatic challenge (Herman et al., 2016). 
Through the release of glucocorticoids, the HPA axis mobilizes energy reserves to ensure 
that the organism has the resources needed to meet a real or perceived threat. Correct 
control of this system is essential to maintain energy reserves and not create 
physiological stress reactions at inappropriate times. As KCNH8 is strongly expressed in 
the pituitary, this increased anxiety-like phenotype in the KCNH8 mutant mice would 
suggest pathologic change in this signaling cascade within the mice.  
In addition, epinephrine and norepinephrine are produced by the adrenal medulla 
through sympathetic stimulation and the local effects of cortisol. These hormones 
positively feedback to the pituitary and increase the breakdown of Proopiomelanocortin 
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(POMC) into Adrenocorticotropic hormone (ACTH) and β-endorphins (Valenta, Elias, & 
Eisenberg, 1986). In turn, the increased endogenous levels of β-endorphins could 
significantly alter acute (and chronic) pain thresholds (Mohammed et al., 2018; Qiu et al., 
2017). These data may suggest the usefulness of appraising Jeffery with a number of 
clinical anxiety questionnaires. However, there may also exist differences between the 
mutant mouse line and patient phenotypes based on differences in normo-expression and 
function of the KCNH8 channel between species. Further work is required to determine 
the mechanisms that underlie this anxiety-like phenotype in the mice. 
The lack of differences between mutant and WT mice in Rota-Rod (Figure 4C) 
and grip strength (Figure 4D) assays demonstrates that the truncated KCNH8 channel 
does not likely affect short-term motor coordination or strength. The majority of these 
behavioral tests agree with Jeffrey’s reported symptoms. It still remains uncertain why 
the mutant mice avoided colder ambient temperatures during the thermal plate testing but 
were relatively insensitive to acetone application. With further work, these anomalies can 
hopefully be resolved.  
 
The Heterozygous Mutant ITSN2 Protein Manifests as Altered Neuronal Excitability  
 Sarah’s reported thermal pain condition appears to stem from her altered ITSN2 
protein. Interestingly, the erythromelalgia phenotype produced is similar to patients with 
gain-of-function Nav1.7 mutations, although genetic analyses indicated no changes in 
Sarah’s SCN9A gene. Here, transgenic mice harboring this ITSN2 point mutation were 
studied in a thermal plate assay (Figure 5) to explore their preferred temperature. 
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Gabapentin injections were then administered to this mouse line to see if any reversal of 
pain phenotype could be produced. This was performed because Sarah’s treatments with 
the drug reduce her thermally-induced pain (as reported by Dr. Charles Berde of BCH). It 
has been demonstrated that gabapentin administration has a role in decreasing calcium 
channel expression and related neurotransmitter vesicle synaptic output. As this reduction 
in catecholamine release can decrease nociceptive signaling to calm chronic pain (Chen 
et al., 2018; Hendrich et al., 2008; Todd, McDavid, Brindley, Jewell, & Currie, 2012), 
gabapentin can likely counteract the hyperactive state produced by aberrant ITSN2-
mediated signaling. Thus, gabapentin’s reversal of the potential altered sensitivity in the 
ITSN2 mutant mice will be informative in two ways. It will both propose that ITSN2 is 
the correct target, and that it acts in vesicle release to create and alter pain phenotypes as 
its role in other systems and its connection with WNK1 would suggest. 
 At temperatures between 17-21°C, the mutant ITSN2 mice preferred the constant 
25°C plate more than their WT littermates (Figure 5A). This behavior is likely indicative 
of hypersensitivity to ambient cold temperatures, through greater than normal sensory 
excitability at these temperatures. Additionally, results in Figure 5B indicate that the 
mutant ITSN2 mice have a significant preference for 41°C over 25°C, as compared to 
WT mice (p<0.01). A possible explanation is that the ITSN2 mutant mice are 
desensitized to hotter temperatures because of constant nociceptive input from “ambient 
warm” at room temperature. Interestingly this phenotype also occurs in hyperactive 
Nav1.7 mutant mice designed to phenocopy erythromelalgia patients, suggesting a 
commonality between these cellular mechanisms which produce peripheral nociceptive 
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hyperactivity that leads to desensitization. Furthermore, it is possible that this 
desensitized phenotype is similar to how patients use varying doses of capsaicin cream 
and patches to aid in peripheral pain. Capsaicin at first stimulates nociceptors through 
selective agonism of the TRPV1 receptor (Park et al., 2007), and it has been proposed 
that it may induce functional destabilization of the associated neural signaling as a means 
of relieving patient pain (B. K. Campbell et al., 2017; Knotkova, Pappagallo, & Szallasi, 
2008; Malmberg et al., 2004).  
If the ITSN2 mutant mice are active at room temperature, then their PNS may be 
desensitized to detecting ambient heat, leading to what appears contrary to an 
erythromelalgia patient phenotype. As wild-type mice find the 25°C plate mildly 
uncomfortable, the ITSN2 mice would be expected to have a similar or possibly stronger 
aversive phenotype at this same temperature. However, as they are possibly desensitized 
to ambient heat but not ambient cool, the animals actively spend more time on the hotter 
plates, as is demonstrated in Figure 5B. 
 
Gabapentin Reverses the Altered Excitability Produced by the ITSN2 Mutation 
As indicated in Figure 5C and 5D, intraperitoneal gabapentin administration 
shifted the temperature preference of ITSN2 mice toward the WT behavior in colder 
temperatures (p=0.169) and somewhat in warmer temperatures. Gabapentin has been 
reported to normalize sensory hypersensitivity (Bannister et al., 2017) and is effective 
against ongoing pain in Sarah. The observed reversal supports the hypothesis that the 
ITSN2 mice have increased sensitivity to and discomfort at ambient cold temperatures, 
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and that gabapentin decreases this phenotype. Interestingly the gabapentin administered 
during heat thermal testing appeared to decrease the time spent on the hotter plate in the 
mutant mice. Here, gabapentin may be reducing desensitization, normalizing their 
behavior toward that of the wild type mice at 37°C and 41°C. Gabapentin therefore helps 
restore a normal level of neuronal excitability under both hot and cold conditions, 
although the exact mechanism of its activity needs to be assessed. In addition, further 
mice will need to be tested to determine if these differences can achieve statistical 
significance, though results from this initial cohort of animals are extremely encouraging. 
 
 Additional Behavioral Tests Reveal the Limited Effects of this ITSN2 Mutation 
Outside of her erythromelalgia episodes, Sarah has not yet reported abnormal 
mechanical sensitivity or other non-thermal characteristics. The von Frey, acetone, 
activity wheels, elevated plus maze, Rota-Rod, and grip strength assays in the transgenic 
mutant ITSN2 mice were used to explore possible undocumented effects of the mutation. 
A slight increase in von Frey sensitivity observed in some ITSN2 mice (p=0.176) could 
indicate increased mechanical sensitivity, though this data is not conclusive and would 
require additional trials and a larger samples size. It would also be interesting to learn 
more about Sarah’s mechanical hyperalgesia by testing the response of the mice to paw 
pressure with an analgesiometer (Sánchez-Fernández et al., 2013), which is designed to 
test a response to noxious mechanical input. The lack of difference between groups upon 
acetone administration (Figure 5F), reveals that this brief direct cold application may not 
cause as much potential hypersensitivity as the consistently cold floor during cold 
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thermal plate testing (Figure 5A). As data from these two means of measuring cold 
sensitivity also differed in the KCNH8 mice, further experimental analysis will be 
required. The possible activity increase observed during activity wheel testing (p=.1957) 
could also be a yet unexplored effect of the mutation. Similar results between the mutant 
ITSN2 mice and WT group during anxiety, balance, and strength testing signifies that 
these phenotypes were unaffected by the ITSN2 point mutation.  
 
 
Conclusions 
The use of CRISPR/Cas9 genome editing in pain models provides a new powerful 
means of reproducing and studying human pain conditions. The observed differences 
between both of the animal models discussed here and their associated human patients 
indicates that further analysis of the patients will be useful. Additionally, increasing the 
number of mice in behavioral tests and repeating trials with multiple groups may help 
elucidate further details of these rare congenital mutations.   
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